Urinary polyamines in colorectal cancer

Jon S Thompson, James A. Edney, Kevin Laughlin

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Urine polyamine content is increased in patients with colorectal malignancy and may be a useful tumor marker in the management of these patients. Urinary excretion of putrescine and spermidine was measured preoperatively and in the first week postoperatively in nine patients with inflammatory bowel disease, eight with other benign colorectal disease, and 13 with colorectal cancer. Preoperative urine putrescine levels were elevated similarly in patients with inflammatory bowel disease and malignancy. Polyamine levels were increased in all three groups in the early postoperative period. Urinary polyamine excretion did not correlate with serum CEA levels, tumor volume, or stage of disease in patients with cancer. Because elevated levels of urinary polyamines are not specific for malignancy and do not correlate with other prognostic indicators, such measurements are unlikely to be useful in tumor detection and determining prognosis. Polyamine levels, however, may prove useful in monitoring response to therapy and detecting recurrences in individual patients.

Original languageEnglish (US)
Pages (from-to)873-877
Number of pages5
JournalDiseases of the Colon & Rectum
Volume29
Issue number12
DOIs
StatePublished - Dec 1 1986

Fingerprint

Polyamines
Colorectal Neoplasms
Putrescine
Neoplasms
Inflammatory Bowel Diseases
Urine
Spermidine
Tumor Biomarkers
Tumor Burden
Postoperative Period
Recurrence
Serum

Keywords

  • Colon cancer
  • Polyamines
  • Ulcerative colitis

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Urinary polyamines in colorectal cancer. / Thompson, Jon S; Edney, James A.; Laughlin, Kevin.

In: Diseases of the Colon & Rectum, Vol. 29, No. 12, 01.12.1986, p. 873-877.

Research output: Contribution to journalArticle

Thompson, Jon S ; Edney, James A. ; Laughlin, Kevin. / Urinary polyamines in colorectal cancer. In: Diseases of the Colon & Rectum. 1986 ; Vol. 29, No. 12. pp. 873-877.
@article{27a6f99a18c94a079a89d12b743763d8,
title = "Urinary polyamines in colorectal cancer",
abstract = "Urine polyamine content is increased in patients with colorectal malignancy and may be a useful tumor marker in the management of these patients. Urinary excretion of putrescine and spermidine was measured preoperatively and in the first week postoperatively in nine patients with inflammatory bowel disease, eight with other benign colorectal disease, and 13 with colorectal cancer. Preoperative urine putrescine levels were elevated similarly in patients with inflammatory bowel disease and malignancy. Polyamine levels were increased in all three groups in the early postoperative period. Urinary polyamine excretion did not correlate with serum CEA levels, tumor volume, or stage of disease in patients with cancer. Because elevated levels of urinary polyamines are not specific for malignancy and do not correlate with other prognostic indicators, such measurements are unlikely to be useful in tumor detection and determining prognosis. Polyamine levels, however, may prove useful in monitoring response to therapy and detecting recurrences in individual patients.",
keywords = "Colon cancer, Polyamines, Ulcerative colitis",
author = "Thompson, {Jon S} and Edney, {James A.} and Kevin Laughlin",
year = "1986",
month = "12",
day = "1",
doi = "10.1007/BF02555367",
language = "English (US)",
volume = "29",
pages = "873--877",
journal = "Diseases of the Colon and Rectum",
issn = "0012-3706",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Urinary polyamines in colorectal cancer

AU - Thompson, Jon S

AU - Edney, James A.

AU - Laughlin, Kevin

PY - 1986/12/1

Y1 - 1986/12/1

N2 - Urine polyamine content is increased in patients with colorectal malignancy and may be a useful tumor marker in the management of these patients. Urinary excretion of putrescine and spermidine was measured preoperatively and in the first week postoperatively in nine patients with inflammatory bowel disease, eight with other benign colorectal disease, and 13 with colorectal cancer. Preoperative urine putrescine levels were elevated similarly in patients with inflammatory bowel disease and malignancy. Polyamine levels were increased in all three groups in the early postoperative period. Urinary polyamine excretion did not correlate with serum CEA levels, tumor volume, or stage of disease in patients with cancer. Because elevated levels of urinary polyamines are not specific for malignancy and do not correlate with other prognostic indicators, such measurements are unlikely to be useful in tumor detection and determining prognosis. Polyamine levels, however, may prove useful in monitoring response to therapy and detecting recurrences in individual patients.

AB - Urine polyamine content is increased in patients with colorectal malignancy and may be a useful tumor marker in the management of these patients. Urinary excretion of putrescine and spermidine was measured preoperatively and in the first week postoperatively in nine patients with inflammatory bowel disease, eight with other benign colorectal disease, and 13 with colorectal cancer. Preoperative urine putrescine levels were elevated similarly in patients with inflammatory bowel disease and malignancy. Polyamine levels were increased in all three groups in the early postoperative period. Urinary polyamine excretion did not correlate with serum CEA levels, tumor volume, or stage of disease in patients with cancer. Because elevated levels of urinary polyamines are not specific for malignancy and do not correlate with other prognostic indicators, such measurements are unlikely to be useful in tumor detection and determining prognosis. Polyamine levels, however, may prove useful in monitoring response to therapy and detecting recurrences in individual patients.

KW - Colon cancer

KW - Polyamines

KW - Ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=0023003726&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023003726&partnerID=8YFLogxK

U2 - 10.1007/BF02555367

DO - 10.1007/BF02555367

M3 - Article

C2 - 3792170

AN - SCOPUS:0023003726

VL - 29

SP - 873

EP - 877

JO - Diseases of the Colon and Rectum

JF - Diseases of the Colon and Rectum

SN - 0012-3706

IS - 12

ER -